Skip to main content
Natraj Proteins Ltd. logo

Natraj Proteins Ltd. — Investor Relations & Filings

Ticker · 530119 ISIN · INE444D01016 LEI · 335800OT5NBQ2WY22K41 BSE.NS Manufacturing
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS 530119

About Natraj Proteins Ltd.

https://natrajproteins.com/

Natraj Proteins Ltd. specializes in the solvent extraction and refining of edible oils, primarily focusing on soybean processing. The company operates a comprehensive manufacturing facility equipped for the production of refined soybean oil and de-oiled cake (DOC). Its core business activities encompass the procurement of oilseeds, extraction processes, and the distribution of high-quality vegetable oils for human consumption alongside protein-rich meal for the animal feed industry. Natraj Proteins Ltd. serves both domestic markets and international clients through the export of its soy-based products. The company maintains a focus on operational efficiency and quality standards within the oilseed processing sector, positioning itself as a key supplier of essential food ingredients and agricultural commodities.

Recent filings

Filing Released Lang Actions
Pursuant to Reg.24A of SEBI Listing Regulations and Master Circular issued by SEBI, We are pleased to submit the Annual Secretarial Compliance report for the year ended on 31.03.2026
Regulatory Filings Classification · 88% confidence The document is a SEBI‐mandated Secretarial Compliance Report filed by the Company Secretary and submitted to BSE under Regulation 24A of SEBI (LODR). It comprises an attestation of compliance rather than detailed financial statements or a simple announcement of an upcoming report. Per the certification rule, any standalone compliance certificate or officer attestation (even if referencing a formal report) is classified under Regulatory Filings (RNS).
2026-05-25 English
Submission of newspaper advertisement publication related to extract of Quarterly/yearly Audited financial results of the Company for the Quarter and Year ended 31st March, 2026
Regulatory Filings Classification · 82% confidence The document is a letter from Natraj Proteins Limited to the BSE submitting the press clipping (newspaper advertisement) of the extract of quarterly and yearly audited financial results under SEBI (LODR) Regulations. It does not include the full financial statements or substantive data itself, but fulfills a regulatory disclosure requirement. This is therefore a general compliance/regulatory filing, best classified as RNS.
2026-05-24 English
We are pleased to submit the audited financial result for the quarter/year ended on 31.03.2026 alongwith Statement of Assets and Liabilities and Cash Flow.
Interim / Quarterly Report Classification · 85% confidence The document is an official SEBI (LODR) Regulation 33 submission to the stock exchange providing the detailed audited standalone financial results for the quarter (Q4) and year ended March 31, 2026, including the full Statement of Assets & Liabilities, Cash Flow Statement, and the Independent Auditor’s Report. It contains substantive financial statements and data (not merely highlights), making it a periodic financial report rather than a simple earnings release or full annual report, and aligns with the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-22 English
we are pleased to submit the Audited Financial Results along with Statement of Assets and Liabilities and Cash Flow and Auditors' Report thereon by Statutory Auditors for the Quarter/Year ....
Regulatory Filings Classification · 75% confidence The document is an official SEBI (LODR) Regulation 33 submission to the stock exchange containing the board‐approved audited financial results for the quarter and year ended 31 March 2026, the declaration of an unmodified auditor’s report, the full Independent Auditor’s Report, and the Statement of Standalone Audited Financial Results (P&L, assets & liabilities, cash flows). This is a regulatory compliance filing under SEBI LODR rather than a full Annual Report (10‐K), simple earnings release, or proxy/materials. There is no separate investor presentation or notice to download a report; the full financial data and audit opinions are embedded. It best fits the “Regulatory Filings (RNS)” category as a continuous disclosure to the exchange.
2026-05-22 English
Natraj Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve the following businesses along ....
Board/Management Information Classification · 95% confidence The document is a corporate announcement under SEBI regulations notifying the scheduling of a Board Meeting to consider and approve the audited financial results for the quarter/year ended 31st March 2026. It mentions the agenda items including approval of audited financial results, audit report, and financial statements. The document is short (2458 characters) and serves as a notice of an upcoming board meeting rather than containing the actual financial results or detailed reports. Therefore, it is an announcement related to management or board information about meeting scheduling and agenda, not the actual report or results themselves.
2026-05-19 English
Registrar and Share Transfer agent of the Company M/S Ankit Consultancy Private Limited has dispatched the letter to the holders of physical securities related to mandatorily furnishing ....
Regulatory Filings Classification · 95% confidence The document is a letter from Natraj Proteins Limited addressed to BSE Limited regarding the dispatch of KYC letters to shareholders. It references SEBI circulars mandating shareholders to furnish PAN, KYC contact details, bank account details, and nomination information. The document includes instructions for shareholders on compliance and submission of these details. It is an announcement related to regulatory compliance and shareholder communication, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. The document is primarily an official regulatory communication about KYC compliance and shareholder information updates, fitting best under Regulatory Filings (RNS).
2026-05-09 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.